182 related articles for article (PubMed ID: 30703387)
1. Modulation of inflammatory gene transcripts in psoriasis vulgaris: Differences between ustekinumab and etanercept.
Brodmerkel C; Li K; Garcet S; Hayden K; Chiricozzi A; Novitskaya I; Fuentes-Duculan J; Suarez-Farinas M; Campbell K; Krueger JG
J Allergy Clin Immunol; 2019 May; 143(5):1965-1969. PubMed ID: 30703387
[No Abstract] [Full Text] [Related]
2. Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review.
Fleming P; Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Siu S; Kraft J; Lynde C; Pope JE; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B; Gulliver WP
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1063-70. PubMed ID: 25490866
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR.
Mason KJ; Barker JNWN; Smith CH; Hampton PJ; Lunt M; McElhone K; Warren RB; Yiu ZZN; Griffiths CEM; Burden AD;
JAMA Dermatol; 2018 May; 154(5):581-588. PubMed ID: 29590279
[TBL] [Abstract][Full Text] [Related]
4. Secukinumab significantly reduces psoriasis-related work impairment and indirect costs compared with ustekinumab and etanercept in the United Kingdom.
Warren RB; Halliday A; Graham CN; Gilloteau I; Miles L; McBride D
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2178-2184. PubMed ID: 29846965
[TBL] [Abstract][Full Text] [Related]
5. Absolute Versus Relative Psoriasis Area and Severity Index in Clinical Practice.
Del Alcázar Viladomiu E; Lamas Doménech N; Salleras Redonnet M
Actas Dermosifiliogr (Engl Ed); 2019 Sep; 110(7):606-610. PubMed ID: 30803689
[No Abstract] [Full Text] [Related]
6. European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC.
Nast A; Gisondi P; Ormerod AD; Saiag P; Smith C; Spuls PI; Arenberger P; Bachelez H; Barker J; Dauden E; de Jong EM; Feist E; Jacobs A; Jobling R; Kemény L; Maccarone M; Mrowietz U; Papp KA; Paul C; Reich K; Rosumeck S; Talme T; Thio HB; van de Kerkhof P; Werner RN; Yawalkar N
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2277-94. PubMed ID: 26481193
[No Abstract] [Full Text] [Related]
7. The Use of Methotrexate, Alone or in Combination With Other Therapies, for the Treatment of Palmoplantar Psoriasis.
Wald JM; Klufas DM; Strober BE
J Drugs Dermatol; 2015 Aug; 14(8):888-92. PubMed ID: 26267735
[TBL] [Abstract][Full Text] [Related]
8. Ustekinumab in patients previously treated with TNFα inhibitors: a real-life study.
Pinheiro RR; Duarte B; Ferreira A; Cabete J
Eur J Dermatol; 2018 Feb; 28(1):89-91. PubMed ID: 29400282
[No Abstract] [Full Text] [Related]
9. Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis.
Phan C; Beauchet A; Burztejn AC; Severino-Freire M; Barbarot S; Girard C; Lasek A; Reguiai Z; Hadj-Rabia S; Abasq C; Brenaut E; Droitcourt C; Perrussel M; Mallet S; Phan A; Lacour JP; Khemis A; Bourrat E; Chaby G; Deborde R; Plantin P; Maruani A; Piram M; Maccari F; Fougerousse AC; Kupfer-Bessaguet I; Balguérie X; Barthelemy H; Martin L; Quiles-Tsimaratos N; Mery-Brossard L; Pallure V; Lons-Danic D; Bouilly-Auvray D; Beylot-Barry M; Puzenat E; Aubin F; Mahé E; ;
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1984-1992. PubMed ID: 30883928
[TBL] [Abstract][Full Text] [Related]
10. Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective.
Ross C; Marshman G; Grillo M; Stanford T
Australas J Dermatol; 2016 May; 57(2):137-40. PubMed ID: 25754697
[TBL] [Abstract][Full Text] [Related]
11. Acrodermatitis continua of Hallopeau response to optimized biological therapy.
Adas A; Dadban A; Arnault JP; Chaby G; Lok C
Dermatol Online J; 2019 Feb; 25(2):. PubMed ID: 30865417
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis.
van den Reek JMPA; Coenen MJH; van de L'Isle Arias M; Zweegers J; Rodijk-Olthuis D; Schalkwijk J; Vermeulen SH; Joosten I; van de Kerkhof PCM; Seyger MMB; Zeeuwen PLJM; de Jong EMGJ
Br J Dermatol; 2017 May; 176(5):1288-1296. PubMed ID: 27564082
[TBL] [Abstract][Full Text] [Related]
13. A Case Series of Patients With Psoriasis Exposed to Biologic Therapy During Pregnancy: The BIOBADADERM Register and a Review of the Literature.
Echeverría-García B; Nuño-González A; Dauden E; Vanaclocha F; Torrado R; Belinchón I; Pérez-Zafrilla B;
Actas Dermosifiliogr; 2017 Mar; 108(2):168-170. PubMed ID: 27765165
[No Abstract] [Full Text] [Related]
14. Comorbidity as a predictor for drug survival of biologic therapy in patients with psoriasis.
Jacobi A; Rustenbach SJ; Augustin M
Int J Dermatol; 2016 Mar; 55(3):296-302. PubMed ID: 26470689
[TBL] [Abstract][Full Text] [Related]
15. Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients.
D'Amico F; Granata M; Skarmoutsou E; Trovato C; Lovero G; Gangemi P; Longo V; Pettinato M; Mazzarino MC
Inflamm Res; 2018 Jul; 67(7):609-616. PubMed ID: 29605872
[TBL] [Abstract][Full Text] [Related]
16. Pharmacy costs of specialty medications for plaque psoriasis in the United States.
Yang EJ; Beck KM; Sekhon S; Bhutani T
J Am Acad Dermatol; 2019 Jan; 80(1):274-275. PubMed ID: 29673778
[No Abstract] [Full Text] [Related]
17. Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review.
Garber C; Creighton-Smith M; Sorensen EP; Dumont N; Gottlieb AB
J Drugs Dermatol; 2015 Aug; 14(8):881-6. PubMed ID: 26267734
[TBL] [Abstract][Full Text] [Related]
18. Effects of adalimumab, etanercept and ustekinumab on the expression of psoriasin (S100A7) in psoriatic skin.
D'Amico F; Trovato C; Skarmoutsou E; Rossi GA; Granata M; Longo V; Gangemi P; Pettinato M; Mazzarino MC
J Dermatol Sci; 2015 Oct; 80(1):38-44. PubMed ID: 26276441
[TBL] [Abstract][Full Text] [Related]
19. Switching biologics in severe pediatric psoriasis: a retrospective analysis.
Ramos Pinheiro R; Diamantino F; Cabete J; Brasileiro A; Baptista J; Lopes MJP
Int J Dermatol; 2017 Dec; 56(12):1461-1464. PubMed ID: 28960270
[No Abstract] [Full Text] [Related]
20. Survival rates of biological therapies for psoriasis treatment in real-world clinical practice: A Canadian multicentre retrospective study.
Marinas JE; Kim WB; Shahbaz A; Qiang JK; Greaves S; Yeung J
Australas J Dermatol; 2018 Feb; 59(1):e11-e14. PubMed ID: 27858976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
